Healthcare of Ontario Pension Plan Trust Fund Invests $43.74 Million in Henry Schein, Inc. (NASDAQ:HSIC)

Healthcare of Ontario Pension Plan Trust Fund purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC) in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund purchased 600,000 shares of the company’s stock, valued at approximately $43,740,000.

A number of other hedge funds and other institutional investors have also modified their holdings of HSIC. Clarkston Capital Partners LLC grew its holdings in Henry Schein by 5.4% in the third quarter. Clarkston Capital Partners LLC now owns 1,397,805 shares of the company’s stock valued at $101,900,000 after purchasing an additional 71,560 shares during the period. Nuance Investments LLC grew its holdings in Henry Schein by 22.3% in the third quarter. Nuance Investments LLC now owns 2,278,081 shares of the company’s stock valued at $166,072,000 after purchasing an additional 414,748 shares during the period. Thompson Siegel & Walmsley LLC purchased a new stake in Henry Schein in the second quarter valued at approximately $46,683,000. SG Americas Securities LLC grew its holdings in Henry Schein by 1,622.3% in the third quarter. SG Americas Securities LLC now owns 458,828 shares of the company’s stock valued at $33,449,000 after purchasing an additional 432,187 shares during the period. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new stake in Henry Schein in the third quarter valued at approximately $515,000. 96.62% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on the stock. Evercore ISI boosted their target price on shares of Henry Schein from $70.00 to $74.00 and gave the company an “in-line” rating in a report on Tuesday, October 8th. JPMorgan Chase & Co. reduced their price target on shares of Henry Schein from $88.00 to $80.00 and set an “overweight” rating on the stock in a research report on Monday, August 12th. StockNews.com raised shares of Henry Schein from a “sell” rating to a “hold” rating in a research report on Thursday, November 7th. UBS Group reduced their price target on shares of Henry Schein from $75.00 to $72.00 and set a “neutral” rating on the stock in a research report on Wednesday, August 7th. Finally, Barrington Research reaffirmed an “outperform” rating and set a $82.00 price target on shares of Henry Schein in a research report on Wednesday, November 6th. Six investment analysts have rated the stock with a hold rating, four have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $79.38.

Henry Schein Trading Up 0.5 %

HSIC opened at $77.66 on Thursday. The stock has a market capitalization of $9.68 billion, a PE ratio of 31.96, a P/E/G ratio of 2.20 and a beta of 0.87. The firm’s fifty day moving average price is $71.15 and its 200 day moving average price is $69.78. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 12-month low of $63.67 and a 12-month high of $82.63.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 5th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.17 by $0.05. The firm had revenue of $3.17 billion for the quarter, compared to analysts’ expectations of $3.24 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The firm’s quarterly revenue was up .4% on a year-over-year basis. During the same period in the prior year, the company posted $1.32 earnings per share. As a group, research analysts expect that Henry Schein, Inc. will post 4.78 EPS for the current fiscal year.

Insider Activity at Henry Schein

In other Henry Schein news, SVP Lorelei Mcglynn sold 21,035 shares of the business’s stock in a transaction on Friday, September 6th. The shares were sold at an average price of $69.30, for a total transaction of $1,457,725.50. Following the completion of the sale, the senior vice president now owns 71,833 shares in the company, valued at $4,978,026.90. The trade was a 22.65 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, COO Michael S. Ettinger sold 12,240 shares of the business’s stock in a transaction on Monday, November 18th. The shares were sold at an average price of $75.00, for a total transaction of $918,000.00. Following the sale, the chief operating officer now owns 87,706 shares of the company’s stock, valued at approximately $6,577,950. The trade was a 12.25 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by corporate insiders.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.